112 related articles for article (PubMed ID: 27475960)
1. In vitro antimicrobial synergy of colistin with rifampicin and carbapenems against colistin-resistant Acinetobacter baumannii clinical isolates.
Hong DJ; Kim JO; Lee H; Yoon EJ; Jeong SH; Yong D; Lee K
Diagn Microbiol Infect Dis; 2016 Oct; 86(2):184-9. PubMed ID: 27475960
[TBL] [Abstract][Full Text] [Related]
2. In-vitro evaluation of different antimicrobial combinations with and without colistin against carbapenem-resistant Acinetobacter baumannii clinical isolates.
Müderris T; Dursun Manyaslı G; Sezak N; Kaya S; Demirdal T; Gül Yurtsever S
Eur J Med Res; 2024 Jun; 29(1):331. PubMed ID: 38880888
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of apramycin (EBL-1003) in combination with colistin, meropenem, minocycline or sulbactam against XDR/PDR Acinetobacter baumannii isolates from Greece.
Galani I; Souli M; Katsala D; Karaiskos I; Giamarellou H; Antoniadou A
J Antimicrob Chemother; 2024 May; 79(5):1101-1108. PubMed ID: 38501368
[TBL] [Abstract][Full Text] [Related]
4. In vitro synergy of colistin combinations against colistin-resistant Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae isolates.
Vidaillac C; Benichou L; Duval RE
Antimicrob Agents Chemother; 2012 Sep; 56(9):4856-61. PubMed ID: 22751540
[TBL] [Abstract][Full Text] [Related]
5. Comparison of in vitro synergy between polymyxin B or colistin in combination with 16 antimicrobial agents against multidrug-resistant Acinetobacter baumannii isolates.
Wang Y; Ma Y; Xiong L; Wang X; Zhou Y; Chi X; Chen T; Fu H; Luo Q; Xiao Y
J Microbiol Immunol Infect; 2024 Apr; 57(2):300-308. PubMed ID: 38350840
[TBL] [Abstract][Full Text] [Related]
6. Enhancing effect of natural adjuvant, panduratin A, on antibacterial activity of colistin against multidrug-resistant Acinetobacter baumannii.
Thadtapong N; Chaturongakul S; Napaswad C; Dubbs P; Soodvilai S
Sci Rep; 2024 Apr; 14(1):9863. PubMed ID: 38684853
[TBL] [Abstract][Full Text] [Related]
7. Comparative Evaluation of Colistin Susceptibility Testing Methods among Carbapenem-Nonsusceptible Klebsiella pneumoniae and Acinetobacter baumannii Clinical Isolates.
Dafopoulou K; Zarkotou O; Dimitroulia E; Hadjichristodoulou C; Gennimata V; Pournaras S; Tsakris A
Antimicrob Agents Chemother; 2015 Aug; 59(8):4625-30. PubMed ID: 26014928
[TBL] [Abstract][Full Text] [Related]
8. Can Plazomicin Alone or in Combination Be a Therapeutic Option against Carbapenem-Resistant Acinetobacter baumannii?
García-Salguero C; Rodríguez-Avial I; Picazo JJ; Culebras E
Antimicrob Agents Chemother; 2015 Oct; 59(10):5959-66. PubMed ID: 26169398
[TBL] [Abstract][Full Text] [Related]
9. Resazurin microplate test method for rapid determination of colistin resistance in carbapenem-resistant Acinetobacter baumanii isolates.
Yildirim K; Simsek E; Kocak O; Bozkurt S; Koyuncu Ozyurt O; Coban AY
Lab Med; 2024 May; 55(3):380-385. PubMed ID: 38007395
[TBL] [Abstract][Full Text] [Related]
10. In-vitro activity of polymyxin B, rifampicin, tigecycline alone and in combination against carbapenem-resistant Acinetobacter baumannii in Singapore.
Lim TP; Tan TY; Lee W; Sasikala S; Tan TT; Hsu LY; Kwa AL
PLoS One; 2011 Apr; 6(4):e18485. PubMed ID: 21533030
[TBL] [Abstract][Full Text] [Related]
11. Synergistic Activity of Niclosamide in Combination With Colistin Against Colistin-Susceptible and Colistin-Resistant
Ayerbe-Algaba R; Gil-Marqués ML; Jiménez-Mejías ME; Sánchez-Encinales V; Parra-Millán R; Pachón-Ibáñez ME; Pachón J; Smani Y
Front Cell Infect Microbiol; 2018; 8():348. PubMed ID: 30338245
[TBL] [Abstract][Full Text] [Related]
12. Different surface charge of colistin-susceptible and -resistant Acinetobacter baumannii cells measured with zeta potential as a function of growth phase and colistin treatment.
Soon RL; Nation RL; Cockram S; Moffatt JH; Harper M; Adler B; Boyce JD; Larson I; Li J
J Antimicrob Chemother; 2011 Jan; 66(1):126-33. PubMed ID: 21081544
[TBL] [Abstract][Full Text] [Related]
13. Evaluating the antibacterial effect of meropenem-loaded chitosan/sodium tripolyphosphate (TPP) nanoparticles on Acinetobacter baumannii isolated from hospitalized patients.
Amini MS; Baseri Salehi M; Bahador N
BMC Infect Dis; 2024 Jun; 24(1):631. PubMed ID: 38914964
[TBL] [Abstract][Full Text] [Related]
14. Sub-inhibitory concentrations of colistin and imipenem impact the expression of biofilm-associated genes in Acinetobacter baumannii.
Bhavya JN; Anugna SS; Premanath R
Arch Microbiol; 2024 Mar; 206(4):169. PubMed ID: 38489041
[TBL] [Abstract][Full Text] [Related]
15. Can flow cytometric measurements of reactive oxygen species levels determine minimal inhibitory concentrations and antibiotic susceptibility testing for Acinetobacter baumannii?
Yeo JH; Low JQ; Begam N; Leow WT; Kwa AL
PLoS One; 2024; 19(6):e0305939. PubMed ID: 38913680
[TBL] [Abstract][Full Text] [Related]
16. Invitro Activities of Polymyxins and Rifampicin against Carbapenem Resistant
Muthusamy D; Sudhishnaa S; Boppe A
J Clin Diagn Res; 2016 Sep; 10(9):DC15-DC18. PubMed ID: 27790432
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory Effects of Carvacrol on Biofilm Formation in Colistin Heteroresistant
Pakzad I; Yarkarami F; Kalani BS; Shafieian M; Hematian A
Curr Drug Discov Technol; 2024; 21(1):e280923221542. PubMed ID: 37779401
[TBL] [Abstract][Full Text] [Related]
18. Early initiation of three-drug combinations for the treatment of carbapenem-resistant A. baumannii among COVID-19 patients.
Heil EL; Claeys KC; Kline EG; Rogers TM; Squires KM; Iovleva A; Doi Y; Banoub M; Noval MM; Luethy PM; Shields RK
J Antimicrob Chemother; 2023 Apr; 78(4):1034-1040. PubMed ID: 36869724
[TBL] [Abstract][Full Text] [Related]
19. Antiparasitic nitazoxanide potentiates colistin against colistin-resistant
Xu M; Yao Z; Kong J; Tang M; Liu Q; Zhang X; Shi S; Zheng X; Cao J; Zhou T; Wang Z
Microbiol Spectr; 2024 Jan; 12(1):e0229523. PubMed ID: 38032179
[TBL] [Abstract][Full Text] [Related]
20. Comparison of methods for the detection of in vitro synergy in multidrug-resistant gram-negative bacteria.
Gaudereto JJ; Neto LVP; Leite GC; Espinoza EPS; Martins RCR; Villas Boa Prado G; Rossi F; Guimarães T; Levin AS; Costa SF
BMC Microbiol; 2020 Apr; 20(1):97. PubMed ID: 32299353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
